Name: AstraZeneca CEO: Investing in Chinese market essential for innovation
Uploaded: 2026-01-30T20:51:12+08:00
Duration: PT45.04S
Description: Due to the booming development of the Chinese market and China's fundamental role in innovation ecosystems, AstraZeneca plans to invest 100 billion yuan ($14.2 billion) in China for research and production, said Pascal Soriot, CEO of AstraZeneca.

Language

RSS

Newsletters

Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

00:45

Due to the booming development of the Chinese market and China's fundamental role in innovation ecosystems, AstraZeneca plans to invest 100 billion yuan ($14.2 billion) in China for research and production, said Pascal Soriot, CEO of AstraZeneca.

Open in CGTN APP for better experience

Search Trends